China's diabetes devices market is projected to grow from $7.19 billion in 2025 to $14.51 billion by 2034, at a CAGR of 8.11%. Growth is fueled by increasing diabetes prevalence, an aging population, healthcare reforms, and adoption of advanced glucose monitoring and insulin devices. Challenges include cost sensitivity and uneven insurance coverage. Key players like Roche, Abbott, and Medtronic lead the market, while technological progress and government support continue to expand access and affordability.
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by rising demand for rapid diagnostics, AI integration, and precision veterinary medicine, alongside i...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by increasing demand for rapid diagnostics, AI integration, robotic workflows, and a focus on companio...
